Drs. Niraj Desai and Christine Durand talk with CBS Baltimore about transplanting patients with hepatitis C-infected kidneys. The Johns Hopkins trial includes 10 patients from Baltimore, 5 of which have already been transplanted.
This is now a viable option now the hepatitis C is curable. This has the potential to shrink the transplant waitlist which is currently over 200,000 people in the US, 82-percent of whom need kidneys.
“If we had enough organs, we wouldn’t do this,” says Dr. Desai.